Cannabis Science Inc (CBIS) 0.0144 $CBIS
Cannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, "Cannabis Kills Cancer," a Celebratory Fund Raiser
Marketwire Canada - Thu Jun 16, 7:12AM CDT
LOS ANGELES, CA--(Marketwired - Jun 16, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, partners with FHP.TV & Kush Boys Studios to host its "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fund raising event, coined "Cannabis Kills Cancer."
Cannabis Science to Host Black Tie, Red Carpet Event in Los Angeles: "Cannabis Kills Cancer," a Celebratory Fundraiser Dinner Event for Celebrities, Scientists, Doctors, Patients, and Loyalty Shareholders Alike
Marketwire Canada - Fri Jun 10, 11:19AM CDT
COLORADO SPRINGS, CO--(Marketwired - Jun 10, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, to host "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fundraising event, "Cannabis Kills Cancer." Celebrities and Shareholders alike will join in on this unparalleled occasion to raise money for targeted cancer treatments using cannabinoids and unprecedented drug development expansions.
CBIS Delegation Completes Successful Trip to South Africa and Namibia and Launches Historic African Healthcare Initiative Led by Co-Founder, Mr. Raymond C. Dabney
Marketwire Canada - Tue Jun 07, 11:43AM CDT
WASHINGTON, DC--(Marketwired - Jun 7, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces the CBIS African healthcare infrastructure delegation led by Mr. Raymond Dabney and including Dr. Julius Garvey, member of the Scientific Advisory Board of CBIS, Dr. Allen Herman, Chief Medical Officer of CBIS, and Mr. Melvin Foote, President & CEO of Constituency for Africa has just concluded with outstanding results. The delegation has met the prime objectives of the trip to South Africa and is now planning the next steps and trip for a follow up implementation program.
CBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant Beverage, Canna POW!
Marketwire Canada - Thu Jun 02, 10:01AM CDT
NEUNKIRCHEN-RICHELBACH, GERMANY--(Marketwired - Jun 2, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced Cannabis Science Europe GmbH, a European subsidiary of Cannabis Science Inc., based in Germany, released the newest innovative product line: Canna POW! The first worldwide, premium quality, water soluble Cannabis Instant Beverage: Canna POW! Is starting distribution June 1, 2016, in Europe and Internationally.
CBIS African Delegation Arrives in Johannesburg, South Africa After Successful Cape Town Meetings With South African Parliament Members, University Cannabis Research Specialists, and Tour of NIH Equivalent, South African Medical Research Council (MRC)
Marketwired - Wed May 25, 8:44AM CDT
JOHANNESBURG, SOUTH AFRICA--(Marketwired - May 25, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines -- The CBIS delegation led by Mr. Raymond C. Dabney has arrived in Johannesburg, South Africa after a series of successful meetings and in-depth discussions in Cape Town, South Africa with South African Parliament members, key University cannabis research specialists, private industry front-runners, topped off with a tour and meetings with key executives at the South African Medical Research Council (MRC) which is the NIH equivalent research organization in South Africa.
Cannabis Science Delegation Arrives in South Africa to Launch a Historic Africa Healthcare Initiative Led by President & CEO, Co-Founder, Mr. Raymond C. Dabney
Marketwire Canada - Mon May 23, 7:31AM CDT
CAPE TOWN, SOUTH AFRICA--(Marketwired - May 23, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces arrival of a Cannabis Science delegation beginning in Cape Town, South Africa to launch a historic Africa Healthcare initiative led by President & CEO, Co-Founder Raymond C. Dabney.
CBIS Gets Set to Break Ground on Its 360,000 sq. ft. Ft. McDermitt Drug Development Project; Chief William Bills of the Fort McDermitt Tribal Allotment Indian Lands Tours Property With Investors/Licensees With 1 Million sq. ft. of Cultivation Licenses
Marketwired - Mon May 09, 7:51AM CDT
Ft. McDermitt Allotment Allottees Lands, Which Is on the Ft. McDermitt Tribal Reservation, the Project Will Benefit Both Ft. McDermitt Tribe Members and Allotment Allottees
Cannabis Science CEO Launches Raymond C. Dabney University (RCDU) and Releases Schematics for Approx. 40 Acres (1.5 Million Sq. Ft.) With the McDermitt Indian Reservation for the Nevada Drug Development Complex
Marketwire Canada - Fri May 06, 8:30AM CDT
LOS ANGELES, CA--(Marketwired - May 6, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to unveil schematics for its first drug development complex. Cannabis Science CEO releases Raymond C. Dabney University out of California, which is the cornerstone of the Nevada Drug Development Complex. The complete property development deal is approximately 40 acres, spanning more than 1.5 million square feet located in McDermitt, Nevada.
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial, Potential Harborside Resolution, and the DEA's Possible Decision to Re-Schedule Sooner Than We Think
Marketwire Canada - Wed May 04, 9:22AM CDT
COLORADO SPRINGS, CO--(Marketwired - May 4, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to publicly applaud the Drug Enforcement Agency (DEA) for their latest decision to green light clinical trials on the effectiveness of smoked marijuana as a treatment option for post-traumatic stress disorder, proposed Harborside resolution, and the re-scheduling for mass access to expanded treatments. These recent moves by the DEA seem to be signaling the signs of changing times, the right Industry at the right time.
Cannabis Science CEO Sees Over 3,000 Shareholders Registering for Their Loyalty Gifts, as the Company Looks at Plans Coming Together to Unveil the Schematics of Its 360,000 sq. ft. Nevada Drug Development Complex Within the Next Few Days
Marketwired - Tue May 03, 10:22AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, is currently processing more than 3,000 shareholder requests for their "loyalty gift" from CEO Raymond C. Dabney. This is a remarkable number to say the least, as the company draws near the release of the schematics for its 360,000 sq. ft., Nevada drug development complex later this week.
Cannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, "Cannabis Kills Cancer," a Celebratory Fund Raiser
Marketwire Canada - Thu Jun 16, 7:12AM CDT
LOS ANGELES, CA--(Marketwired - Jun 16, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, partners with FHP.TV & Kush Boys Studios to host its "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fund raising event, coined "Cannabis Kills Cancer."
Cannabis Science to Host Black Tie, Red Carpet Event in Los Angeles: "Cannabis Kills Cancer," a Celebratory Fundraiser Dinner Event for Celebrities, Scientists, Doctors, Patients, and Loyalty Shareholders Alike
Marketwire Canada - Fri Jun 10, 11:19AM CDT
COLORADO SPRINGS, CO--(Marketwired - Jun 10, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, to host "black tie, red carpet" event in Los Angeles. Company officials state the gala is a celebratory fundraising event, "Cannabis Kills Cancer." Celebrities and Shareholders alike will join in on this unparalleled occasion to raise money for targeted cancer treatments using cannabinoids and unprecedented drug development expansions.
CBIS Delegation Completes Successful Trip to South Africa and Namibia and Launches Historic African Healthcare Initiative Led by Co-Founder, Mr. Raymond C. Dabney
Marketwire Canada - Tue Jun 07, 11:43AM CDT
WASHINGTON, DC--(Marketwired - Jun 7, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces the CBIS African healthcare infrastructure delegation led by Mr. Raymond Dabney and including Dr. Julius Garvey, member of the Scientific Advisory Board of CBIS, Dr. Allen Herman, Chief Medical Officer of CBIS, and Mr. Melvin Foote, President & CEO of Constituency for Africa has just concluded with outstanding results. The delegation has met the prime objectives of the trip to South Africa and is now planning the next steps and trip for a follow up implementation program.
CBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant Beverage, Canna POW!
Marketwire Canada - Thu Jun 02, 10:01AM CDT
NEUNKIRCHEN-RICHELBACH, GERMANY--(Marketwired - Jun 2, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced Cannabis Science Europe GmbH, a European subsidiary of Cannabis Science Inc., based in Germany, released the newest innovative product line: Canna POW! The first worldwide, premium quality, water soluble Cannabis Instant Beverage: Canna POW! Is starting distribution June 1, 2016, in Europe and Internationally.
CBIS African Delegation Arrives in Johannesburg, South Africa After Successful Cape Town Meetings With South African Parliament Members, University Cannabis Research Specialists, and Tour of NIH Equivalent, South African Medical Research Council (MRC)
Marketwired - Wed May 25, 8:44AM CDT
JOHANNESBURG, SOUTH AFRICA--(Marketwired - May 25, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines -- The CBIS delegation led by Mr. Raymond C. Dabney has arrived in Johannesburg, South Africa after a series of successful meetings and in-depth discussions in Cape Town, South Africa with South African Parliament members, key University cannabis research specialists, private industry front-runners, topped off with a tour and meetings with key executives at the South African Medical Research Council (MRC) which is the NIH equivalent research organization in South Africa.
Cannabis Science Delegation Arrives in South Africa to Launch a Historic Africa Healthcare Initiative Led by President & CEO, Co-Founder, Mr. Raymond C. Dabney
Marketwire Canada - Mon May 23, 7:31AM CDT
CAPE TOWN, SOUTH AFRICA--(Marketwired - May 23, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces arrival of a Cannabis Science delegation beginning in Cape Town, South Africa to launch a historic Africa Healthcare initiative led by President & CEO, Co-Founder Raymond C. Dabney.
CBIS Gets Set to Break Ground on Its 360,000 sq. ft. Ft. McDermitt Drug Development Project; Chief William Bills of the Fort McDermitt Tribal Allotment Indian Lands Tours Property With Investors/Licensees With 1 Million sq. ft. of Cultivation Licenses
Marketwired - Mon May 09, 7:51AM CDT
Ft. McDermitt Allotment Allottees Lands, Which Is on the Ft. McDermitt Tribal Reservation, the Project Will Benefit Both Ft. McDermitt Tribe Members and Allotment Allottees
Cannabis Science CEO Launches Raymond C. Dabney University (RCDU) and Releases Schematics for Approx. 40 Acres (1.5 Million Sq. Ft.) With the McDermitt Indian Reservation for the Nevada Drug Development Complex
Marketwire Canada - Fri May 06, 8:30AM CDT
LOS ANGELES, CA--(Marketwired - May 6, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to unveil schematics for its first drug development complex. Cannabis Science CEO releases Raymond C. Dabney University out of California, which is the cornerstone of the Nevada Drug Development Complex. The complete property development deal is approximately 40 acres, spanning more than 1.5 million square feet located in McDermitt, Nevada.
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial, Potential Harborside Resolution, and the DEA's Possible Decision to Re-Schedule Sooner Than We Think
Marketwire Canada - Wed May 04, 9:22AM CDT
COLORADO SPRINGS, CO--(Marketwired - May 4, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to publicly applaud the Drug Enforcement Agency (DEA) for their latest decision to green light clinical trials on the effectiveness of smoked marijuana as a treatment option for post-traumatic stress disorder, proposed Harborside resolution, and the re-scheduling for mass access to expanded treatments. These recent moves by the DEA seem to be signaling the signs of changing times, the right Industry at the right time.
Cannabis Science CEO Sees Over 3,000 Shareholders Registering for Their Loyalty Gifts, as the Company Looks at Plans Coming Together to Unveil the Schematics of Its 360,000 sq. ft. Nevada Drug Development Complex Within the Next Few Days
Marketwired - Tue May 03, 10:22AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, is currently processing more than 3,000 shareholder requests for their "loyalty gift" from CEO Raymond C. Dabney. This is a remarkable number to say the least, as the company draws near the release of the schematics for its 360,000 sq. ft., Nevada drug development complex later this week.
